Ignite Creation Date:
2025-12-26 @ 10:44 PM
Ignite Modification Date:
2026-04-06 @ 2:59 PM
Study NCT ID:
NCT03113812
Status:
COMPLETED
Last Update Posted:
2017-04-14
First Post:
2017-04-04
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Repeated Subcutaneous Administration of ABvac40 in Mild to Moderate Alzheimer's Disease Patients
Sponsor:
Araclon Biotech S.L.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
AB1203
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None